GLIPR2: a potential biomarker and therapeutic target unveiled - Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.

Authors:
Lin W; Zhang S; Gu C; Zhu H; Liu Y.

Journal:
Front Immunol

Publication Year: 2024

DOI:
10.3389/fimmu.2024.1280525

PMCID:
PMC10929020

PMID:
38476239

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Front Immunol

Detailed journal information not available.

Publication Details

Subject Category: Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Funding Disclosure

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by Nantong Municipal Health Commission Project Fund (M2022041, MS2022069), Nantong Science and Technology Project Fund (JC22022025)."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025